FDA Drug recall D-0488-2017
Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles, Rx only, Moore's Pharmacy Compounding, Corpus Christi, TX
- FDA Drug
- Class II
- terminated
- Published 2017-03-01
On 2017-03-01 the FDA classified a Class II recall of Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles, Rx only, Moore's Pharmacy Compounding, Corpus Christi, TX by Moore S Compounding Pharmacy, citing superpotent Drug and Subpotent Drug; potency failures obtained.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0488-2017 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2016-09-12 |
| Published | 2017-03-01 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Moore S Compounding Pharmacy |
| Distribution | TX |
Product
Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles, Rx only, Moore's Pharmacy Compounding, Corpus Christi, TX
Reason
Superpotent Drug and Subpotent Drug; potency failures obtained
Identifiers
| code_info | 2016-08-22:37@28, exp 2/18/2017 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0488-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.